
Mesothelioma.net reviews the wide array of latest advances in treatment and care for patients affected by the challenging cancer as …

The December edition of Pharmafocus is live and available to read online now!Brexit continues to dominate the headlines inside and …

Bad news for Johnson & Johnson as it emerges that the US pharma giant has been ordered to pay out …

GSK is to back out of a licensing deal with California-based Five Prime Therapeutics to develop a mesothelioma drug. Announcing …

